🇺🇸 FDA
Patent

US 12209255

Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof

granted A61KA61K35/28A61K35/51

Quick answer

US patent 12209255 (Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof) held by Astellas Institute for Regenerative Medicine expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Astellas Institute for Regenerative Medicine
Grant date
Tue Jan 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K35/28, A61K35/51